These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3062147

  • 1. Increased cardiac allograft rejection in female heart transplant recipients.
    Crandall BG, Renlund DG, O'Connell JB, Burton NA, Jones KW, Gay WA, Doty DB, Karwande SV, Lee HR, Holland C.
    J Heart Transplant; 1988; 7(6):419-23. PubMed ID: 3062147
    [Abstract] [Full Text] [Related]

  • 2. Heart transplantation in females.
    Esmore D, Keogh A, Spratt P, Jones B, Chang V.
    J Heart Lung Transplant; 1991; 10(3):335-41. PubMed ID: 1854761
    [Abstract] [Full Text] [Related]

  • 3. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
    Renlund DG, O'Connell JB, Gilbert EM, Hammond ME, Burton NA, Jones KW, Karwande SV, Doty DB, Menlove RL, Herrick CM.
    Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Unique antithymocyte serum versus OKT3 for induction immunotherapy after heart transplantation.
    Frist WH, Merrill WH, Eastburn TE, Atkinson JB, Stewart JR, Hammon JW, Bender JW.
    J Heart Transplant; 1990 Apr; 9(5):489-94. PubMed ID: 2121921
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR, Goldman MH, Hastillo A, Szentpetery S, Wolfgang T, Thompson J, Mohanakumar T, Katz MR, Rider S, Hanrahan J.
    J Heart Transplant; 1985 Apr; 4(4):381-4. PubMed ID: 3916511
    [Abstract] [Full Text] [Related]

  • 9. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.
    Taylor DO, Bristow MR, O'Connell JB, Price GD, Hammond EH, Doty DB, Karwande SV, Gay WA, Jones KW, Lappé D, Renlund DG.
    J Heart Lung Transplant; 1996 Oct; 15(10):1039-46. PubMed ID: 8913922
    [Abstract] [Full Text] [Related]

  • 10. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR, Koch DM, Fisher SG, Heroux AL, Kao WG, Johnson MR.
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [Abstract] [Full Text] [Related]

  • 11. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N, Dunkler D, Kocher A, Imhof M, Grimm M, Zuckermann A, Wolner E, Laufer G.
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
    Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Valantine HA, Wiederhold V, Stinson EB.
    Circulation; 1989 Nov; 80(5 Pt 2):III100-5. PubMed ID: 2805287
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of recipient and donor gender on outcome after heart transplantation.
    Fabbri A, Bryan AJ, Sharples LD, Dunning J, Caine N, Schofield P, Wallwork J, Large SR.
    J Heart Lung Transplant; 1992 Nov; 11(4 Pt 1):701-7. PubMed ID: 1498135
    [Abstract] [Full Text] [Related]

  • 15. Reversal of recalcitrant cardiac allograft rejection with methotrexate.
    Costanzo-Nordin MR, Grusk BB, Silver MA, Sobotka PA, Winters GL, O'Connell JB, Pifarré R, Robinson JA.
    Circulation; 1988 Nov; 78(5 Pt 2):III47-57. PubMed ID: 3052918
    [Abstract] [Full Text] [Related]

  • 16. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
    Stojanovic I, Vrtovec B, Radovancevic B, Radovancevic R, Yazdanbakhsh AP, Thomas CD, Frazier OH.
    J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
    [Abstract] [Full Text] [Related]

  • 17. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review.
    Wagoner LE, Taylor DO, Olsen SL, Bristow MR, O'Connell JB, Hammond EH, Lappe DL, Renlund DG.
    Clin Transplant; 1996 Oct; 10(5):437-43. PubMed ID: 8930458
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression.
    Renlund DG, Bristow MR, Crandall BG, Burton NA, Doty DB, Karwande SV, Gay WA, Jones KW, Hegewald MG, Hagan ME.
    J Heart Transplant; 1989 Oct; 8(3):214-9; discussion 219-20. PubMed ID: 2661771
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda.
    Chinnock R, Emery J, Larsen R, Baum M, Janner D, Razzouk A, Gundry S, Nehlsen-Cannarella S, Bailey L.
    J Heart Lung Transplant; 1995 Oct; 14(4):726-33. PubMed ID: 7578182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.